IV 116th CONGRESS 1st Session H. RES. 242 IN THE HOUSE OF REPRESENTATIVES March 18, 2019 Mr. Butterfield (for himself and Mr. Bilirakis ) submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.